Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(3S,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol has anti-oomycete potential.
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 3,710 | 待询 | ||
1 mL * 10 mM (in DMSO) | ¥ 3,810 | 待询 |
产品描述 | (3S,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol has anti-oomycete potential. |
体外活性 | METHODS AND RESULTS:The resinous exudates from Escallonia illinita by products was characterized by FT-IR, NMR and HRMS. Six compounds were isolated and identified as follows: 1,5-diphenylpent-1-en-3-one (1), 4-(5-hydroxy-3,7-dimethoxy-4-oxo-4H-chromen-2-yl)phenyl acetate (2), pinocembrin (3), kaempferol 3-O-methylether (4), (3S,5S)-(E)-1,7-diphenylhept-1-ene-3,5-diol ((3S,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol ,5) and the new diarylheptanoid (3S,5S)-(E)-5-hydroxy-1,7-diphenylhept-1-en-3-yl acetate (6). The anti-oomycete potential of the resinous exudate, as well as the main compounds, was tested in vitro against Saprolegnia parasitica and Saprolegnia australis. CONCLUSIONS: The resinous exudate showed a strong anti-oomycete activity. In addition, the compounds 6, 1 and 3 demonstrated significant inhibition of Saprolegnia strains development. These findings strongly suggest that E. illinita is a potential biomass that could be used as a natural anti-oomycete product. |
分子量 | 282.38 |
分子式 | C19H22O2 |
CAS No. | 87095-75-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
(3S,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol 87095-75-8 1,7-Diphenylhept-1-ene-3,5-diol (3S,5S,E) 1,7 Diphenylhept 1 ene 3,5 diol (3S,5S,E)1,7Diphenylhept1ene3,5diol Inhibitor inhibitor inhibit